Logo image of NCI

NEO-CONCEPT INTL GROUP HLD-A (NCI) Stock Fundamental Analysis

NASDAQ:NCI - Nasdaq - KYG6421C1125 - Common Stock - Currency: USD

0.3726  +0.02 (+4.66%)

After market: 0.3804 +0.01 (+2.09%)

Fundamental Rating

1

NCI gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 48 industry peers in the Textiles, Apparel & Luxury Goods industry. NCI may be in some trouble as it scores bad on both profitability and health. NCI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

NCI had positive earnings in the past year.
In the past year NCI has reported a negative cash flow from operations.
NCI Yearly Net Income VS EBIT VS OCF VS FCFNCI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 -20M -40M

1.2 Ratios

NCI's Return On Assets of -0.84% is on the low side compared to the rest of the industry. NCI is outperformed by 62.50% of its industry peers.
Looking at the Return On Invested Capital, with a value of 27.88%, NCI belongs to the top of the industry, outperforming 93.75% of the companies in the same industry.
Industry RankSector Rank
ROA -0.84%
ROE N/A
ROIC 27.88%
ROA(3y)16.01%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NCI Yearly ROA, ROE, ROICNCI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 -50 -100 -150

1.3 Margins

Looking at the Operating Margin, with a value of 2.92%, NCI is doing worse than 66.67% of the companies in the same industry.
Looking at the Gross Margin, with a value of 18.73%, NCI is doing worse than 87.50% of the companies in the same industry.
Industry RankSector Rank
OM 2.92%
PM (TTM) N/A
GM 18.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NCI Yearly Profit, Operating, Gross MarginsNCI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 5 10 15 20

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), NCI is creating value.
NCI has about the same amout of shares outstanding than it did 1 year ago.
Compared to 1 year ago, NCI has an improved debt to assets ratio.
NCI Yearly Shares OutstandingNCI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 5M 10M 15M 20M
NCI Yearly Total Debt VS Total AssetsNCI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 20M 40M 60M 80M

2.2 Solvency

An Altman-Z score of 2.43 indicates that NCI is not a great score, but indicates only limited risk for bankruptcy at the moment.
NCI has a worse Altman-Z score (2.43) than 64.58% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 2.43
ROIC/WACC2.4
WACC11.63%
NCI Yearly LT Debt VS Equity VS FCFNCI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 -20M -40M -60M

2.3 Liquidity

NCI has a Current Ratio of 0.91. This is a bad value and indicates that NCI is not financially healthy enough and could expect problems in meeting its short term obligations.
NCI's Current ratio of 0.91 is on the low side compared to the rest of the industry. NCI is outperformed by 93.75% of its industry peers.
A Quick Ratio of 0.84 indicates that NCI may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.84, NCI is doing worse than 75.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.91
Quick Ratio 0.84
NCI Yearly Current Assets VS Current LiabilitesNCI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 20M 40M 60M 80M 100M

0

3. Growth

3.1 Past

NCI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -17.83%.
Looking at the last year, NCI shows a very negative growth in Revenue. The Revenue has decreased by -40.41% in the last year.
EPS 1Y (TTM)-17.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%129.36%
Revenue 1Y (TTM)-40.41%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%1.72%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NCI Yearly Revenue VS EstimatesNCI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 100M 200M 300M

2

4. Valuation

4.1 Price/Earnings Ratio

NCI is valuated reasonably with a Price/Earnings ratio of 9.31.
Compared to the rest of the industry, the Price/Earnings ratio of NCI indicates a rather cheap valuation: NCI is cheaper than 81.25% of the companies listed in the same industry.
NCI is valuated cheaply when we compare the Price/Earnings ratio to 25.82, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 9.32
Fwd PE N/A
NCI Price Earnings VS Forward Price EarningsNCI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

NCI's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.86
NCI Per share dataNCI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for NCI!.
Industry RankSector Rank
Dividend Yield N/A

NEO-CONCEPT INTL GROUP HLD-A

NASDAQ:NCI (5/23/2025, 7:21:26 PM)

After market: 0.3804 +0.01 (+2.09%)

0.3726

+0.02 (+4.66%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.99%
Inst Owner Change0%
Ins Owners1.9%
Ins Owner Change0%
Market Cap7.57M
Analysts60
Price TargetN/A
Short Float %4.57%
Short Ratio0.16
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 9.32
Fwd PE N/A
P/S 0.23
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 10.86
EPS(TTM)0.04
EY10.74%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.32
FCFYN/A
OCF(TTM)-0.31
OCFYN/A
SpS1.59
BVpS-0.02
TBVpS-0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.84%
ROE N/A
ROCE 35.39%
ROIC 27.88%
ROICexc 38.79%
ROICexgc 38.79%
OM 2.92%
PM (TTM) N/A
GM 18.73%
FCFM N/A
ROA(3y)16.01%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)2.05%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover2.78
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 879.33%
Cap/Sales 0.51%
Interest Coverage 1.2
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.91
Quick Ratio 0.84
Altman-Z 2.43
F-Score3
WACC11.63%
ROIC/WACC2.4
Cap/Depr(3y)318.66%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.26%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-17.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%129.36%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-40.41%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%1.72%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-52.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-17.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-15.12%
OCF growth 3YN/A
OCF growth 5YN/A